期刊
SEMINARS IN OPHTHALMOLOGY
卷 26, 期 3, 页码 77-93出版社
TAYLOR & FRANCIS INC
DOI: 10.3109/08820538.2011.577129
关键词
ARMS2/HTRA1; CFH; choroidal neovascularization; complement; geographic atrophy; susceptibility
资金
- NEI NIH HHS [P30 EY014800] Funding Source: Medline
Age-related macular degeneration (AMD) is a progressive degenerative disease which leads to blindness, affecting the quality of life of millions of Americans. More than 1.75 million individuals in the United States are affected by the advanced form of AMD. The etiological pathway of AMD is not yet fully understood, but there is a clear genetic influence on disease risk. To date, the 1q32 (CFH) and 10q26 (PLEKHA1/ARMS2/HTRA1) loci are the most strongly associated with disease; however, the variation in these genomic regions alone is unable to predict disease development with high accuracy. Therefore, current genetic studies are aimed at identifying new genes associated with AMD and their modifiers, with the goal of discovering diagnostic or prognostic biomarkers. Moreover, these studies provide the foundation for further investigation into the pathophysiology of AMD by utilizing a systems-biology-based approach to elucidate underlying mechanistic pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据